These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 18044061)
1. Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality. Salpeter SR Int J Chron Obstruct Pulmon Dis; 2007; 2(1):11-8. PubMed ID: 18044061 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. Salpeter SR; Buckley NS; Salpeter EE J Gen Intern Med; 2006 Oct; 21(10):1011-9. PubMed ID: 16970553 [TBL] [Abstract][Full Text] [Related]
3. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study. Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937 [TBL] [Abstract][Full Text] [Related]
4. Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids. Salpeter SR; Buckley NS Clin Rev Allergy Immunol; 2006; 31(2-3):219-30. PubMed ID: 17085795 [TBL] [Abstract][Full Text] [Related]
5. The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease. Kliber A; Lynd LD; Sin DD Respir Res; 2010 May; 11(1):56. PubMed ID: 20459831 [TBL] [Abstract][Full Text] [Related]
6. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease? Reddy CB; Kanner RE Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532 [TBL] [Abstract][Full Text] [Related]
7. Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease. Sethi S; Cote C Curr Clin Pharmacol; 2011 Feb; 6(1):48-61. PubMed ID: 21235463 [TBL] [Abstract][Full Text] [Related]
8. Contemporary management of chronic obstructive pulmonary disease: scientific review. Sin DD; McAlister FA; Man SF; Anthonisen NR JAMA; 2003 Nov; 290(17):2301-12. PubMed ID: 14600189 [TBL] [Abstract][Full Text] [Related]
13. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes. Hanania NA Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470 [TBL] [Abstract][Full Text] [Related]
14. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease. Beeh KM; Beier J Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ; Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710 [TBL] [Abstract][Full Text] [Related]
16. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids. Hodder R; Kesten S; Menjoge S; Viel K Int J Chron Obstruct Pulmon Dis; 2007; 2(2):157-67. PubMed ID: 18044688 [TBL] [Abstract][Full Text] [Related]
17. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Hanania NA Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761 [TBL] [Abstract][Full Text] [Related]